Shareholders of Natco Pharma will be eligible to avail two rights shares for every 21 shares held as on the record date. Previous Post Can CarTrade Tech shares sustain above the ₹3,000 mark? Here's what analysts said about its new partnership Next Post Embassy Office Parks REIT raises ₹1,000 crore through NCDs from European bank Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment
